Hepatocellular carcinoma (HCC) is the most common primary liver cancer worldwide. The
onset of the disease is occult and develops rapidly. As a result, the disease is often detected …

Simple Summary Liver cancer is one of the most devastating human malignancies
worldwide, especially in Asia, where over 70% of new cases are diagnosed. Most liver …

In recent years, the incidence of liver cancer has increased and is currently the sixth most
common tumor and the second leading cause of cancer‑associated mortality worldwide …

Hepatocellular carcinoma (HCC) is the most common primary liver malignancy worldwide
and a leading cause of death worldwide. Its incidence continues to increase in the US due to …

Hepatocellular carcinoma (HCC) is one of the most common malignant tumor in the world
and its incidence is increasing in many countries. In recent years, with the deepening …

Hepatocellular Carcinoma (HCC) is one of the most common malignancies, and its
incidence and mortality are increasing worldwide. Cancer immunotherapy has …

Introduction Hepatocellular carcinoma (HCC) is a major challenge in oncology. It ranks
fourth in most common causes of cancer death worldwide. Despite advancements in cancer …

Hepatocellular carcinoma (HCC) is a prevalent primary liver cancer, representing
approximately 85% of cases. The diagnosis is often made in the middle and late stages …

Despite advances in cancer treatment, hepatocellular carcinoma (HCC), the most common
form of liver cancer, remains a major public health problem worldwide. The immune …

In recent years, immune checkpoint inhibitors (ICIs) have revolutionized the treatment of
patients with hepatocellular carcinoma (HCC). Following the positive results of the …